1. Fig. 3. Kaplan-Meier analyses of biochemical recurrence (BCR)-free survival rates according to ADCmeanvalues among the total subjects (A) and among the 4 different subgroups: pathologic Gleason score ≤7 (B), pathologic Gleason score ≥8 (C), pathologic stage ≤ T2 (D), and pathologic stage ≥ T3 (E). Group A, patients with ADC values <746×10−6 mm2/s; group B, patients with ADC values ≥746×10−6 mm2/s.; ADC, apparent diffusion coefficient.
Fig. 3. Kaplan-Meier analyses of biochemical recurrence (BCR)-free survival rates according to ADCmeanvalues among the total subjects (A) and among the 4 different subgroups: pathologic Gleason score ≤7 (B), pathologic Gleason score ≥8 (C), pathologic stage ≤ T2 (D), and pathologic stage ≥ T3 (E). Group A, patients with ADC values <746×10−6 mm2/s; group B, patients with . . .
Investig Clin Urol Jan;58(1):